Marca Nominativa depositada no INPI em 08/11/2022 por QUIDELORTHO CORPORATION, processo nº 501728787, nas classes 01, 05, 09, 10, 42. Registro em vigor até 08/11/2032.
| Número do processo | 501728787 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 08/11/2022 |
| Data da concessão | 29/10/2024 |
| Vigência até | 08/11/2032 |
| Titular | QUIDELORTHO CORPORATION |
| UF · País | — · US |
Diagnostic reagent test kits comprised of monoclonal antibodies, buffers, and reagents for scientific or research use; diagnostic reagent test kits comprising detection and identification staining reagents and associated quality control reagents for clinical laboratory use.;
In vitro medical diagnostic test kits for clinical, professional, medical or consumer use consisting primarily of medical diagnostic reagents together with test equipment in the nature of a medical testing device for monitoring medical conditions and diagnosing viral, inflammatory and infectious diseases, and diagnosing and monitoring genetic diseases for medical use; chemical, biochemical and biological preparations for medical use in cassette form, namely, for use in measuring, testing and analyzing blood and other bodily fluids; chemical reagents in cassette form for medical purposes, namely, for use in connection with diagnostic test kits for the detection of a wide variety of diseases, conditions, and disorders; diagnostic reagent test kits comprising detection and identification staining reagents and associated quality control reagents for medical and clinical use; diagnostic reagent test kits comprised of monoclonal antibodies, buffers, and reagents for clinical or medical laboratory use.;
In vitro medical diagnostic test kits for clinical, professional, medical or consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring conditions and diagnosing disease (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations);
Automated molecular diagnostic instrument for clinical laboratory use in detecting pathogens; clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; automated fluorescent-based microscopy system comprising light-emitting diodes (LED), objective lens, digital camera charge-coupled device (CCD), motorized slide carrier, and diagnostic software for data reduction; wireless routers; gateway routers in the nature of computer control hardware; computer software for capturing, organizing, reporting, and management of medical information and data; diagnostic reagent test kits comprising customized microscopy slides, for clinical laboratory use; diagnostic reagent test kits comprising customized microscopy slides, for medical and clinical use.;
Devices in the nature of glass slides, cups, bags for the collection of bodily excretions and fluids from humans for medical diagnostic purposes; devices in the nature of glass slides, cups, bags and test components in the nature of medical testing devices sold as a kit for the collection, preservation and shipment of bodily excretions and fluids from humans for clinical medical diagnostic purposes; medical diagnostic apparatus comprised of an optics window, a port for a reagent test, and an illuminating device, specifically adapted for reading in vitro medical test results; medical diagnostic analyzers for measuring, testing and analyzing blood and other bodily fluids.;
Providing an on-line non-downloadable web-based software that allows users to access medical information and data; providing temporary use of on-line non-downloadable cloud computing software for capturing, organizing, reporting, and remote management of medical information and data.;
Providing a website portal featuring technology that allows users to access medical information and data (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations);
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501728787 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas6 despacho(s) publicado(s) na Revista da Propriedade Industrial.